Standard

Nash opyt primeneniia otechestvennogo preparata legochnogo surfaktanta dlia lecheniia sindroma ostrogo povrezhdeniia legkikh i tiazhelykh pnevmonii u detei. / Tsybul'kin, E. K.; Rozenberg, O. A.; Seiliev, A. A.; Volchkov, V. A.; Zaitseva, N. V.; Kuz'menko, I. G.; Loshakova, L. V.; Pelogievskaia, Z. I.; Portniagin, I. V.; Shefer, S. P.

In: Anesteziologiia i reanimatologiia, No. 2, 03.1999, p. 61-65.

Research output: Contribution to journal › Article › peer-review

Harvard

Tsybul'kin, EK, Rozenberg, OA, Seiliev, AA, Volchkov, VA, Zaitseva, NV, Kuz'menko, IG, Loshakova, LV, Pelogievskaia, ZI, Portniagin, IV & Shefer, SP 1999, 'Nash opyt primeneniia otechestvennogo preparata legochnogo surfaktanta dlia lecheniia sindroma ostrogo povrezhdeniia legkikh i tiazhelykh pnevmonii u detei.', Anesteziologiia i reanimatologiia, no. 2, pp. 61-65.

APA

Tsybul'kin, E. K., Rozenberg, O. A., Seiliev, A. A., Volchkov, V. A., Zaitseva, N. V., Kuz'menko, I. G., Loshakova, L. V., Pelogievskaia, Z. I., Portniagin, I. V., & Shefer, S. P. (1999). Nash opyt primeneniia otechestvennogo preparata legochnogo surfaktanta dlia lecheniia sindroma ostrogo povrezhdeniia legkikh i tiazhelykh pnevmonii u detei. Anesteziologiia i reanimatologiia, (2), 61-65.

Vancouver

Tsybul'kin EK, Rozenberg OA, Seiliev AA, Volchkov VA, Zaitseva NV, Kuz'menko IG et al. Nash opyt primeneniia otechestvennogo preparata legochnogo surfaktanta dlia lecheniia sindroma ostrogo povrezhdeniia legkikh i tiazhelykh pnevmonii u detei. Anesteziologiia i reanimatologiia. 1999 Mar;(2):61-65.

Author

Tsybul'kin, E. K. ; Rozenberg, O. A. ; Seiliev, A. A. ; Volchkov, V. A. ; Zaitseva, N. V. ; Kuz'menko, I. G. ; Loshakova, L. V. ; Pelogievskaia, Z. I. ; Portniagin, I. V. ; Shefer, S. P. / Nash opyt primeneniia otechestvennogo preparata legochnogo surfaktanta dlia lecheniia sindroma ostrogo povrezhdeniia legkikh i tiazhelykh pnevmonii u detei. In: Anesteziologiia i reanimatologiia. 1999 ; No. 2. pp. 61-65.

BibTeX

@article{549b2adf3b8541aaa2fda6efd7fe57f2,
title = "Nash opyt primeneniia otechestvennogo preparata legochnogo surfaktanta dlia lecheniia sindroma ostrogo povrezhdeniia legkikh i tiazhelykh pnevmonii u detei.",
abstract = "Six critical patients aged 2 months to 13 years with lung diseases were treated by pulmonary surfactant preparation. Three of these children developed the acute respiratory distress syndrome in the presence of grave pneumonia (1 case), asphyxial drowing (1 case), and small-small intestinal invagination (1 case), three others developed acute bilateral large focal pneumonia with or without repeated atelectases. The drug Surfactant-BL was administered in a dose of 400 micrograms/m2 by instillations (2 cases) or by inhalation aerosols. The drug improved blood gases, lung compliance, x-ray picture, and clinical status of all patients, permitting a decrease in IMV/SIMV parameters within 12-48 h after the last administration and discontinuation of IMV/SIMV in 3 patients within 24 h after 1 or two administrations. Five children survived, 1 (with asphyxial drowning) died with brain edema and wedging syndrome. Surfactant-BL is a safe and effective drug; administration through alveolar nebulisers should be preferred.",
author = "Tsybul'kin, {E. K.} and Rozenberg, {O. A.} and Seiliev, {A. A.} and Volchkov, {V. A.} and Zaitseva, {N. V.} and Kuz'menko, {I. G.} and Loshakova, {L. V.} and Pelogievskaia, {Z. I.} and Portniagin, {I. V.} and Shefer, {S. P.}",
year = "1999",
month = mar,
language = "русский",
pages = "61--65",
journal = "Russian Journal of Anesthesiology and Reanimatology /Anesteziologiya i Reanimatologiya",
issn = "0201-7563",
publisher = "Медицина",
number = "2",

}

RIS

TY - JOUR

T1 - Nash opyt primeneniia otechestvennogo preparata legochnogo surfaktanta dlia lecheniia sindroma ostrogo povrezhdeniia legkikh i tiazhelykh pnevmonii u detei.

AU - Tsybul'kin, E. K.

AU - Rozenberg, O. A.

AU - Seiliev, A. A.

AU - Volchkov, V. A.

AU - Zaitseva, N. V.

AU - Kuz'menko, I. G.

AU - Loshakova, L. V.

AU - Pelogievskaia, Z. I.

AU - Portniagin, I. V.

AU - Shefer, S. P.

PY - 1999/3

Y1 - 1999/3

N2 - Six critical patients aged 2 months to 13 years with lung diseases were treated by pulmonary surfactant preparation. Three of these children developed the acute respiratory distress syndrome in the presence of grave pneumonia (1 case), asphyxial drowing (1 case), and small-small intestinal invagination (1 case), three others developed acute bilateral large focal pneumonia with or without repeated atelectases. The drug Surfactant-BL was administered in a dose of 400 micrograms/m2 by instillations (2 cases) or by inhalation aerosols. The drug improved blood gases, lung compliance, x-ray picture, and clinical status of all patients, permitting a decrease in IMV/SIMV parameters within 12-48 h after the last administration and discontinuation of IMV/SIMV in 3 patients within 24 h after 1 or two administrations. Five children survived, 1 (with asphyxial drowning) died with brain edema and wedging syndrome. Surfactant-BL is a safe and effective drug; administration through alveolar nebulisers should be preferred.

AB - Six critical patients aged 2 months to 13 years with lung diseases were treated by pulmonary surfactant preparation. Three of these children developed the acute respiratory distress syndrome in the presence of grave pneumonia (1 case), asphyxial drowing (1 case), and small-small intestinal invagination (1 case), three others developed acute bilateral large focal pneumonia with or without repeated atelectases. The drug Surfactant-BL was administered in a dose of 400 micrograms/m2 by instillations (2 cases) or by inhalation aerosols. The drug improved blood gases, lung compliance, x-ray picture, and clinical status of all patients, permitting a decrease in IMV/SIMV parameters within 12-48 h after the last administration and discontinuation of IMV/SIMV in 3 patients within 24 h after 1 or two administrations. Five children survived, 1 (with asphyxial drowning) died with brain edema and wedging syndrome. Surfactant-BL is a safe and effective drug; administration through alveolar nebulisers should be preferred.

UR - http://www.scopus.com/inward/record.url?scp=0033090091&partnerID=8YFLogxK

M3 - статья

C2 - 10360078

AN - SCOPUS:0033090091

SP - 61

EP - 65

JO - Russian Journal of Anesthesiology and Reanimatology /Anesteziologiya i Reanimatologiya

JF - Russian Journal of Anesthesiology and Reanimatology /Anesteziologiya i Reanimatologiya

SN - 0201-7563

IS - 2

ER -

ID: 85030874